GalaxySpace Completes a New Financing Round with Legend Capital Re-upped

HONG KONG, Sep 25, 2022 – (ACN Newswire) – GalaxySpace, a Chinese commercial aerospace company, recently completed its latest financing round with a post-investment valuation of approximately RMB11 billion. As an existing shareholder, Legend Capital continued to support the company by following up on this financing round.

Legend Capital first invested in GalaxySpace in 2018 and continued to follow up on the company's subsequent financing rounds in 2019, 2020 and 2022, increasing its investment layout of cutting-edge technology and supporting the development of GalaxySpace.

Founded in 2018, GalaxySpace is the first unicorn enterprise in the field of commercial aerospace and satellite internet in China. Xu Ming, founder, chairman and CEO of GalaxySpace, said: "This round of financing will be mainly used for the R&D of satellite Internet-related technologies and the development of commercial applications. GalaxySpace will accelerate the R&D of core technologies such as stackable flat panel satellites, flexible multi-beam phased array technology, flexible solar wings, digital processing payloads, etc., and also the construction of mass-producing low-cost satellites. Step by step, we will move forward to the 6G era of the Internet of Everything."

Nowadays, global space infrastructure construction has been developing rapidly, and commercial aerospace is becoming one of the new driving forces of the world's economic development. According to a Morgan Stanley report, the global space economy is expected to be worth $1 trillion by 2040, and the satellite Internet is expected to account for 50% or even 70% of the market growth.

At present, GalaxySpace's new-generation stackable flat-panel satellite has entered the prototype development stage, which is also the first flat-panel satellite in China and will be launched early next year. It is believed that the development of stackable flat-panel satellites will promote the mass production of satellites and the rapid deployment of large-scale constellations. In the future, GalaxySpace will seize the development opportunities and fully utilize the advantages of small wins and rapid iteration of commercial aerospace to make a continuous innovative contribution to China's satellite Internet construction.

About Legend Capital

Founded in 2001, Legend Capital is a leading VC&PE investor focusing on the early-stage and growth-stage opportunities in China, with offices across Beijing, Shanghai, Shenzhen, Hong Kong, and Seoul, Korea.

It currently manages USD and RMB funds of over US$10 billion in commitments, and has invested in around 600 companies, covering technology, healthcare, consumer, enterprise service and intelligent manufacturing sectors. Rooted in China, Legend Capital participated in the rise of many world-leading companies by solid investment coverage and systematic post-investment value-add. Over the years, Legend Capital has also become a widely recognized name in bridging key resources in China and overseas through cross-border activities, and a valuable partner to Chinese and overseas investors.

Legend Capital values long-term sustainable investment and incorporates ESG into its long-term development strategy. As a UNPRI signatory since November 2019, Legend Capital is among the first group of top VC/PE firms in China to join the initiative.

For more information, please visit www.legendcapital.com.cn/index_en.aspx and follow us on LinkedIn @Legend Capital (https://www.linkedin.com/company/legend-capital).


Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Leadrive Technology Completes Series C Financing, Legend Capital Re-upped

HONG KONG, Sep 25, 2022 – (ACN Newswire) – Leadrive Technology, a leading supplier of power semiconductor and motor control solutions for new energy vehicles, recently announced its completion of the series C financing. As the existing shareholder, Legend Capital continued to support this round of financing.

This round of financing will be mainly used for the construction of the IGBT/SiC power module packaging production line, the operation of the rapid production of motor control products, and the R&D of the latest generation of silicon carbide power modules and motor control products.

Founded in 2017, Leadrive Technology has been committed to the forward development and production of power semiconductor modules and high-performance motor control units, bringing high-quality electric power to global automotive enterprise customers and consumers. After five years of rapid development, Leadrive Technology is equipped with mature technology and product solutions in the power modules and motor control units. A variety of high-performance IGBT power modules and main-drive dual-motor controller products developed by Leadrive have been installed in several hybrid models of many OEMs, achieving mass shipments and fully entering the passenger car market. With many test indicators at the industry-leading level in vehicle testing, the silicon carbide motor controller independently developed by Leadrive has also been designated and recognized by many downstream customers in the global market.

In the future, Leadrive will center on the two core electrification foundations of power semiconductor modules and motor control units, and continue to invest in advanced technology development, product platform iteration, capacity expansion, and other fields. By leveraging its technological advantages, Leadrive works with industry chain partners to empower the electrification trend of the automotive industry and make outstanding contributions to promoting the technological progress of the industry.

Dr. Jie Shen, the CEO of Leadrive, said: "Currently, the company is in a critical stage of rapidly developing large-scale delivery. This round of financing will mainly be used for the construction and implementation of the company's power module packaging production line and the replenishment of working capital for multiple mass production projects. For the smooth delivery of this round of financing, I would like to thank all the new and existing shareholders for their trust and strong support. With pursuing excellence in our mind, we take it as our duty to promote the technological progress of the industry as well as to make a continuous innovative contribution to the development of the new energy vehicle industry in China."

About Legend Capital

Founded in 2001, Legend Capital is a leading VC&PE investor focusing on the early-stage and growth-stage opportunities in China, with offices across Beijing, Shanghai, Shenzhen, Hong Kong, and Seoul, Korea.

It currently manages USD and RMB funds of over US$10 billion in commitments, and has invested in around 600 companies, covering technology, healthcare, consumer, enterprise service and intelligent manufacturing sectors. Rooted in China, Legend Capital participated in the rise of many world-leading companies by solid investment coverage and systematic post-investment value-add. Over the years, Legend Capital has also become a widely recognized name in bridging key resources in China and overseas through cross-border activities, and a valuable partner to Chinese and overseas investors.

Legend Capital values long-term sustainable investment and incorporates ESG into its long-term development strategy. As a UNPRI signatory since November 2019, Legend Capital is among the first group of top VC/PE firms in China to join the initiative.

For more information, please visit www.legendcapital.com.cn/index_en.aspx and follow us on LinkedIn @Legend Capital (https://www.linkedin.com/company/legend-capital).


Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Southern Score Honours Badminton World Champions, Aaron and Wooi Yik with RM100,000 Incentive

KUALA LUMPUR, Sep 24, 2022 – (ACN Newswire) – Southern Score Builders Berhad is pleased to present an incentive of RM100,000 to Malaysia's top men's doubles pair Aaron Chia and Soh Wooi Yik, who won Malaysia's first gold at the 2022 World Badminton Championships in Tokyo last month.


Soh Wooi Yik, Gan Yee Hin and Chia Teng Fong [L-R]

Ian Wong Jien Sern, Gan Yee Hin, Dato Jack Koh [L-R]


Aaron and Wooi Yik were presented with mock cheques by Executive Director and Chief Executive Officer of Southern Score, Gan Yee Hin, at a ceremony today honouring their outstanding achievements. On hand to welcome them were guests and staff of Southern Score.

Gan Yee Hin said, "We are here to celebrate the outstanding achievement of Aaron and Wooi Yik by presenting a token of appreciation for winning the world title for Malaysia. Thank you for the dedication and hard work, they are excellent and truly deserve the rewards. We believe this world title is just the beginning of their badminton journey. We hope this little token of our gratitude will further motivate them for greater achievements and bring glory to the country in the world arena."

"We hope that our gesture incentive will inspire others to assist a new generation of players who have the courage to pursue the sport as their career."

"At the same time, we are contributing RM200,000 to Petaling Badminton Club (PBC), the club from which our world champions were nurtured before they joined the national team. We hope that the contribution provides some support as they nurture talents to represent the country. PBC has had a history of producing several of the country's well-known players such as Chen Tang Jie, Cheam June Wei, Man Wei Chong and Goh V Shem."

Aaron and Wooi Yik thanked Southern Score for the incentive and said, "We are honoured to have represented Malaysia at the World Badminton Championships and would like to thank Southern Score and all Malaysians for their support."

"Support such as this incentive from Southern Score means a lot to us and motivates us as we prepare ourselves mentally and physically to win more accolades for Malaysia on the world stage, including our goal of making it to the 2024 Olympic Games."

Southern Score is a certified CIDB Grade 7 builder of homes for the community and a future for the nation. The Company is always closely tied into the local community and remains active in community involvement programmes such as education, sport, environment and society.

Southern Score: https://southernscore.com.my/

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

CoinSmart Announces Acquisition by Coinsquare, Creating one of Canada’s Largest Crypto Asset Trading Platforms

TORONTO, ON, Sep 23, 2022 – (ACN Newswire) – CoinSmart Financial Inc. ("CoinSmart" or the "Company") (NEO: SMRT) (FSE: IIR), announced today that it has entered into a definitive agreement dated September 22, 2022 (the "Purchase Agreement") with Coinsquare Ltd. ("Coinsquare"), a leading Canadian crypto asset trading platform, pursuant to which CoinSmart has agreed to sell to Coinsquare all of the issued and outstanding shares of its wholly-owned operating subsidiary Simply Digital Technologies Inc. ("Simply Digital") (the "Transaction").

The acquisition and integration of these two businesses will establish Coinsquare as one of Canada's largest crypto asset trading platforms with a diversified and compliant offering across various business lines, including both retail and institutional trading, crypto payment processing, and digital asset custody. CoinSmart will hold approximately 12% ownership in Coinsquare on a pro-forma basis. The combined company has transacted over $10 billion since January 2018, and will have over $350 million in assets under custody with a combined user base in excess of 1 million.

Coinsquare is in the final stages of its approval to become Canada's first crypto asset trading platform regulated as an Investment Industry Regulatory Organization of Canada ("IIROC") dealer and marketplace member.

"Today is an exciting day for all of us at CoinSmart," said CoinSmart CEO Justin Hartzman. "We are thrilled to be working alongside the Coinsquare team to build one of the largest regulated crypto asset trading platforms in Canada and I could not be more proud of what we have accomplished so far. With a diversified product suite, exceptional crypto talent, and one of the largest user bases in Canada, the combined company will be well-positioned to pursue its aggressive expansion plans. While the crypto market is in the building phase of its life cycle, this transaction will provide the torque needed to be in a favourable position entering the next bull run."

"This acquisition represents a monumental and exciting milestone for both companies and brings together two industry leading management teams," said Coinsquare, CEO Martin Piszel. "We are excited to work together to shape how the crypto industry in Canada grows and evolves, and together we will be able to offer our clients the most innovative and secure products backed by the highest standards of regulation in the industry."

Key Transaction Benefits

– One of Canada's Largest Crypto Asset Trading Platforms: combined company will have transacted over $10 billion in crypto transactions since January 2018 and will have over $350 million in assets under custody, together with a diversified and regulated platform across trading, payments, asset management, and digital asset custody.
– Acquisition of Cash and Shares with Upside to Shareholders: consideration payable to CoinSmart at closing of $3 million in cash, and the issuance of 5,222,222 common shares of Coinsquare ("Coinsquare Shares"), with an aggregate deemed value of approximately $26,215,555, plus the ability to receive up to approximately $20 million in additional cash consideration on the achievement of SmartPay business earn-out targets and 1,100,000 Coinsquare Shares on the achievement of over-the-counter ("OTC") business earn-out targets. It is further anticipated that CoinSmart will hold cash (or crypto assets) of approximately $10 million on completion of the Transaction.
– Investment in Canada's only Qualified Custodian for Digital Assets: backed by Coinsquare, Coinbase Ventures and other well-known financial institutions, Tetra Trust is Canada's only qualified custodian for digital assets, and represents significant potential upside for Coinsquare shareholders.
– Exposure to Diversified Investment Portfolio: Coinsquare, through its subsidiary Coinsquare Investments Ltd., holds a diversified investment portfolio in assets, such as FRNT Financial ( TSXV: FRNT) and two Blockchange Ventures funds.
– Management Team to Join Coinsquare: CoinSmart Co-Founders Justin Hartzman, Jeremy Koven, and Michael Koral, amongst others, will join Coinsquare. Justin Hartzman will join the Coinsquare Executive Team and CoinSmart will be entitled to a nominee to join the Coinsquare Board of Directors upon completion of the Transaction.
– Voting Support by Senior Officers and Directors of ~45%: each of the directors and certain senior officers of CoinSmart have entered into support and voting agreements with Coinsquare pursuant to which they have agreed to vote in favour of the Transaction.

Transaction Details

Pursuant to the terms of the Purchase Agreement, Coinsquare will acquire all of the issued and outstanding shares of Simply Digital on a cash-free, debt-free basis.

The purchase price, which is subject to standard post-closing adjustments as set out in the Purchase Agreement, will be satisfied on closing by (i) the payment to CoinSmart of $3 million in cash, and (ii) the issuance of 5,222,222 Coinsquare Shares to CoinSmart. Coinsquare's largest shareholder, Mogo Inc. (NASDAQ: MOGO) (TSX: MOGO), disclosed in their most recent financials that they valued the Coinsquare Shares at approximately $5.02 per Coinsquare Share as of June 30, 2022. There can be no assurance that such value per Coinsquare Share has not changed since June 30, 2022.

Subject to the terms set forth in the Purchase Agreement, additional consideration will be payable to CoinSmart pursuant to the Transaction upon the achievement of certain revenue-based earn-out targets related to CoinSmart's SmartPay business and OTC trading business. Up to an additional $20 million in cash may be payable pursuant to the SmartPay earn-out (over a period of three years following closing of the Transaction) and up to an additional 1,100,000 Coinsquare Shares may be issuable pursuant to the OTC earn-out (over a period of one year following closing of the Transaction).

On completion of the Transaction, CoinSmart will hold approximately 12% of the issued and outstanding Coinsquare Shares. Coinsquare is a privately held company incorporated under the laws of Canada. Other than its interest in Coinsquare Shares and cash, CoinSmart will hold no other material assets immediately following the completion of the Transaction. The Transaction has been unanimously approved by the board of directors of the Company (the "Board").

Under the terms of the Purchase Agreement, the Board may respond to an unsolicited bona fide written proposal that, having regard to all relevant terms and conditions of such proposal, constitutes or could reasonably be expected to constitute or lead to a Superior Proposal (as defined in the Purchase Agreement).

The Transaction will constitute the sale of all or substantially all of the undertaking of CoinSmart pursuant to the Business Corporations Act (British Columbia) and, accordingly, will require approval by not less than two-thirds of the votes cast at a special meeting of the shareholders of CoinSmart (the "Meeting"). CoinSmart currently expects to mail the management information circular in connection with the Meeting to shareholders on or before October 29, 2022, and to hold the Meeting on or before November 29, 2022. Subject to the satisfaction (or waiver) of applicable closing conditions as set forth in the Purchase Agreement, the closing of the Transaction is anticipated to occur in the fourth quarter of 2022.

The management of CoinSmart will be employed by Coinsquare following the closing of the Transaction and will continue to play an active role in the ongoing and future business of Simply Digital (including the SmartPay business and the OTC business).

Board Recommendation

The Board has unanimously determined that the Transaction is in the best interests of CoinSmart. Accordingly, the Board approved the Purchase Agreement and recommends that Shareholders vote in favour of the resolution to approve the Transaction at the Meeting.

Each of the directors and certain senior officers of the Company, collectively holding approximately 45% of the issued and outstanding common shares of the Company, have entered into support and voting agreements with Coinsquare pursuant to which they have agreed to support and vote in favour of the Transaction. In making its determination, the Board considered, among other things, an opinion provided to the Board by Eight Capital to the effect that, based upon and subject to the limitations, assumptions and qualifications stated in such opinion, the consideration to be received by CoinSmart pursuant to the Transaction is fair, from a financial point of view, to CoinSmart.

Financial Advisors and Counsel

In connection with the Transaction, CoinSmart has engaged Eight Capital as its financial advisor and Wildeboer Dellelce LLP as its legal advisor. Coinsquare has engaged Origin Merchant Partners as its financial advisor and Goodmans LLP as its legal advisor.

Additional Information

Complete details of the terms and conditions of the Transaction are set out in the Purchase Agreement, which will be filed by CoinSmart under its profile on SEDAR at www.sedar.com.
In addition, further information regarding the Transaction will be contained in the management information circular in respect of the Meeting which will be filed on SEDAR at the time that it is mailed to shareholders. All shareholders are urged to read the information circular once it becomes available, as it will contain additional important information concerning the Transaction.

About CoinSmart

CoinSmart is a leading Canadian-headquartered crypto asset trading platform dedicated to providing customers with an intuitive way for buying and selling digital assets, like Bitcoin and Ethereum. CoinSmart is one of the few crypto asset trading platforms in Canada to be registered as a securities dealer and marketplace with the Ontario Securities Commission. CoinSmart is also one of the first Canadian headquartered trading platforms to have an international presence, accepting customers across 40+ countries at a time when the digital asset industry continues to rapidly expand. CoinSmart further builds on its mission to make cryptocurrency accessible by providing educational resources tailored to every level of cryptocurrency knowledge and unparalleled 24/7 omni-channel customer support. Offering instant verification, industry leading cold wallet storage, advanced charting with order book functionality and over-the-counter premium services, CoinSmart ensures every client's needs are met with the highest level of quality and care. For more information, please visit www.coinsmart.com.

About Coinsquare

Founded in 2014, Coinsquare, a private company incorporated under the laws of Canada provides customers with a proprietary platform engineered to deliver a robust, secure, and intelligent interface for trading Bitcoin, Ethereum, Litecoin, and other digital assets. Coinsquare has grown to become Canada's oldest operating digital asset firm, trading on behalf of over half a million Canadians. Coinsquare has raised over $100M in capital and has successfully executed trades in excess of $8 billion to date. For more information, please visit www.coinsquare.com.

For further information: Contact Details:

CoinSmart
Justin Hartzman, Chief Executive Officer
Email: ir@coinsmart.com
Tel: 1.647.923.7678

The Top Floor Public Relations
Michele McDermott-Fox
Email: michele@thetopflooragency.com,
Tel: 1.905.379.1893


SOURCE: Platodata.io



FORWARD-LOOKING STATEMENTS

This news release contains "forward-looking information" which may include, but is not limited to, information with respect to the activities, events or developments that the Company expects or anticipates will or may occur in the future. Such forward-looking information is often, but not always, identified by the use of words and phrases such as "plans," "expects," "is expected," "budget," "scheduled," "estimates," "forecasts," "intends," "anticipates," or "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may," "could," "would," "might" or "will" be taken, occur or be achieved. Forward-looking information in this press release includes, among other things, statements and information concerning: the anticipated benefits of the completion of the Transaction; the opportunities available to the combined company on completion of the Transaction; the consideration payable to the Company pursuant to the Transaction, including potential additional consideration payable upon the achievement of specified earn-out targets; the Company's pro-forma ownership of Coinsquare following completion of the Transaction; membership of the Company nominee on the board of Coinsquare following the completion of the Transaction; the requirement for the Company to obtain shareholder approval of the Transaction; the anticipated timing of the Meeting; the parties' ability to satisfy closing conditions, including the receipt of necessary regulatory approvals; and the anticipated timing for completion of the Transaction.

Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the Company. While the Company considers these assumptions to be reasonable based on information currently available to it, they may prove to be incorrect. Forward looking information involves known and unknown risks, uncertainties and other risk factors which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Such risks in respect of forward-looking information in this press release include: risks associated with the Transaction and with purchase and sale transactions generally, such as the failure to satisfy closing conditions contained in the Purchase Agreement, the failure to obtain shareholder or regulatory approvals, and the absence of material adverse changes or other events which may give the parties a basis on which to terminate the Purchase Agreement; and the risk that the Transaction may not close on the anticipated timeline, or at all. In addition there are business risks and uncertainties associated with the digital currency industry generally, including: adapting to technological change, new products and standards; increased competition that adversely affects business; additional competition from new or existing technologies that adversely affect business; software products and/or services may contain undetected errors or "bugs", vulnerabilities or defects; damage or failure of information technology; cybersecurity risks associated with data security and hacking; potential violations of applicable privacy laws; political, economic and other uncertainties in respect of digital currencies; and various other risks as set out in the annual information form of the Company dated March 31, 2022, in respect of the financial year ended December 31, 2021, a copy of which is available under the Company's profile on SEDAR at www.sedar.com. Although the Company has attempted to identify certain important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward- looking information. The Company undertakes no obligation, except as otherwise required by law, to update these forward-looking statements if management's beliefs, estimates or opinions, or other factors change.

The Transaction cannot close until the required shareholder and regulatory approvals are obtained. There can be no assurance that the Transaction will be completed as proposed or at all. The Transaction could be modified, restructured or terminated. Investors are cautioned that, except as disclosed in the Purchase Agreement or management information circular to be delivered to shareholders in connection with the Transaction, copies of each of which are or will be filed under the Company's profile on SEDAR at www.sedar.com, any information released or received with respect to the Transaction may not be accurate or complete and should not be relied upon.

The NEO Exchange Inc. has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

AIM Vaccine Announces Proposed Listing on the Main Board of SEHK

HONG KONG, Sep 23, 2022 – (ACN Newswire) – AIM Vaccine Co., Ltd. ("AIM Vaccine" or the "Company", together with its subsidiaries, the "Group", stock code: 06660.HK), the second largest vaccine company in China in terms of 2021 approved lot release volume (excluding COVID-19 vaccines), announced the proposed listing of its H shares on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK") today.

AIM Vaccine plans to offer an aggregate of 9,714,000 H shares (the "Offer Shares") under the Global Offering (subject to the Over-allotment Option), comprising an international offering (the "International Offering") of 8,742,400 H shares (subject to adjustment and the Over-allotment Option) and Hong Kong public offering (the "Hong Kong Public Offering") of 971,600 H shares (subject to adjustment), at an offer price of HK$16.16 per H share.

The Hong Kong Public Offering will commence at 9:00 a.m. on 23 September 2022 (Friday) and close at 12:00 noon on 28 September 2022 (Wednesday) in Hong Kong. Dealings in H shares of the Company on SEHK are expected to commence at 9:00 a.m. on 6 October 2022 (Thursday), with the stock code 06660.HK in board lots of 200 H shares each.

Goldman Sachs (Asia) L.L.C., China International Capital Corporation Hong Kong Securities Limited, China Securities (International) Corporate Finance Company Limited and Macquarie Capital Limited are the Joint Sponsors, Joint Global Coordinators, Joint Bookrunners and Joint Lead Managers. BOCI Asia Limited, ICBC International Securities Limited, CMB International Capital Limited, Futu Securities International (Hong Kong) Limited, and Tiger Brokers (HK) Global Limited are the Joint Bookrunners and Joint Lead Managers. Livermore Holdings Limited is the Joint Lead Manager.

Empowered by a full spectrum of proven human vaccine platform technologies, covering the full value chain

AIM Vaccine is a major player in the Chinese vaccine industry. According to CIC, the National Medical Products Administration of the PRC ("NMPA") approved lot releases of 623.8 million doses of 46 vaccines against 26 diseases (exclusive of COVID-19 vaccines) in 2021, of which AIM Vaccine contributed 7.4%, or approximately 46 million doses, making AIM Vaccine the second largest vaccine manufacturer group and the largest among all privately-owned vaccine companies in the PRC in terms of approved lot release volume (excluding COVID-19 vaccines). AIM Vaccine covers the full value chain from research and development to manufacturing and to commercialization. According to CIC, AIM Vaccine is the only China-based vaccine player that has all five proven human vaccine platform technologies worldwide, namely bacterial vaccine technologies, viral vaccine technologies, genetically engineered vaccine technologies, combination vaccine technologies and mRNA vaccine technologies, with at least one approved product or one vaccine candidate at CTA or clinical stages under each platform. AIM Vaccine is one of the first two human vaccine companies in the PRC that has been granted permission under the Fourteenth Five Year Plan of the PRC to build a P3 Lab. In response to the current pandemic, AIM Vaccine has taken full advantages of the Group's full-spectrum platform technologies and is developing COVID-19 vaccine candidates spanning multiple technology routes validated by approved vaccines.

AIM Vaccine currently commercializes eight vaccine products against six disease areas, of which the HBV vaccines and human rabies vaccine are its market-leading key commercialized vaccine products. According to CIC, in 2021, AIM Vaccine was the largest supplier of HBV vaccines in the globe and in the PRC, possessing a 45.4% market share in China in terms of approved lot release volume. In 2021, AIM Vaccine was the second largest supplier of human rabies vaccines in the globe and in the PRC, possessing 18.1% and 16.2% market shares of China market, respectively, in terms of approved lot release volume and sales revenue. AIM Vaccine also has 22 vaccine candidates in the Group's pipeline against 13 disease areas, of which five candidates are at clinical stages. AIM Vaccine's comprehensive vaccine product portfolio is empowered by high-quality, commercial-scale manufacturing capabilities of the Group's four individual licensed manufacturing facilities, enabling AIM Vaccine to achieve scalable and quality supply of multiple vaccines. As of 16 September 2022, a total of 45 production permits were granted by the NMPA to 33 vaccine manufacturers or manufacturer groups, and only seven had approved lot releases for four or more products in 2021, including the Group. By obtaining four production permits, the Group is the largest holder of production permits in the PRC among all privately-owned companies, and the second largest holder overall.

Strive to access the best industry resources and innovative technologies to accelerate product development and commercialization

In order to accelerate building up a vaccine portfolio with true market potential, AIM Vaccine is profoundly committed to striving to access the best industry resources. AIM Vaccine currently has four individual licensed manufacturing facilities with differentiated product foci. AIM Vaccine acquired Rong'an Bio, AIM Honesty, AIM Kanghuai and AIM Weixin between 2015 and 2017, together with their vaccine products against human rabies, HBV, HAV, mumps and HFRS. After these acquisitions, AIM Vaccine upgraded the manufacturing infrastructure in each subsidiary to meet the latest GMP standards, improved manufacturing processes and techniques in pursuit of higher product quality and stronger supply capabilities, formulated and executed production plans which closely follow group marketing strategies and consolidated supply chains.

In addition, AIM Vaccine turns science to high-quality vaccine products through a truly interactive R&D and manufacturing process with high efficiency. AIM Vaccine has established dedicated R&D departments in each of the four operating subsidiaries, with a specific focus on developing new vaccine varieties based on their respective leading products and manufacturing specialties. In addition, AIM Explorer, one of the Group's three research institutions, focuses on offering technological support to the four operating subsidiaries with research on early-stage and cutting-edge technologies as its priority. A cross-functional, cross-entity collaboration, which enables AIM Vaccine to consider both biological attributes and sound engineering and manufacturing principles from program inception onwards, could significantly improve R&D success rates and vaccine delivery efficiency. AIM Vaccine realizes a promotive synergy across vaccine R&D and manufacturing. On one hand, AIM Vaccine has ready-for-use commercial-scale manufacturing facilities to harness development of various vaccine candidates. On the other hand, the intensive pilot and scale-up productions of diverse candidates also rapidly refine and improve the Group's process know-how, production facilities, and productivity and skillset of production teams. Such a collaborative development path and culture enable AIM Vaccine to generate 22 vaccine candidates across different development stages.

Leading mRNA COVID-19 vaccine in R&D progress is expected to capture massive market opportunities

The ongoing COVID-19 pandemic has created a massive and sustainable vaccine market in the globe and PRC. To capture such massive and underserved vaccine market opportunities, AIM Vaccine is currently developing vaccines for COVID-19 based on mRNA technology platform and has initiated a global Phase III clinical trial. According to CIC, as of 16 September 2022, there was no approved mRNA COVID-19 vaccine in the PRC. Six PRC vaccine developers were undertaking clinical trials for their respective mRNA COVID-19 vaccine candidates in the PRC or overseas, two of which (including AIM Vaccine) reached Phase III clinical trials. Therefore, AIM Vaccine's mRNA COVID-19 vaccine candidate is expected to be one of the first few to be approved in the PRC. Moreover, AIM Vaccine's mRNA vaccine pilot scale production facility is also among the first one to reach GMP standards in the PRC. In addition, for candidates against variant strains, AIM Vaccine has successfully constructed and produced trial vaccines against different variant strains in preclinical studies, including the Omicron variant strain. AIM Vaccine plans to first obtain NDA approval for and/or launch the Group's mRNA vaccine against the Original Strain in the second quarter of 2023 to address the urgent and near-term market demand. For the longer future, AIM Vaccine plans to launch the broad-spectrum recombinant adenoviral vector vaccine, which is not only effective against COVID-19 variants, but also risks of other coronavirus.

Strong pipeline consisting of market-leading vaccine products and vaccine candidates with large market size

As of 16 September 2022, AIM Vaccine had eight vaccine products against six vaccine-preventable infectious diseases, and 22 vaccine candidates against 13 major vaccine-preventable infectious diseases. According to CIC, the Group's portfolio of vaccine products and vaccine candidates covers all top 10 vaccine products worldwide by 2021 global sales (totaling US$101.9 billion).

Among its vaccine products, HBV vaccines and human rabies vaccines are the Group's key commercialized products, which is the main source of revenue for the Company, and each has a leading position in the corresponding Chinese vaccine market. In addition to these two types of market-leading key commercialized vaccines, AIM Vaccine has other vaccine products against HAV, meningococcal diseases, mumps and HFRS, which diversify the Group's product portfolio and revenue sources.

Among 22 vaccine candidates in the Group's pipeline against 13 disease areas, AIM Vaccine has five candidates at clinical stages, and plans to file over 10 CTAs by the end of 2023 to advance multiple CTA-enabling and preclinical candidates to clinical trial stages. Out of this robust pipeline, AIM Vaccine expects to obtain NDA approvals for and/or launch new vaccine products every year from 2023 to 2025 and 12 other new products in and after 2026, to bring sustainable new growth drivers to the Group's business with a continuously diversifying product portfolio.

Strong R&D capabilities fueled up by the full-spectrum proven human vaccine platform technologies, and mass-scale manufacturing capabilities with proven quality management

AIM Vaccine is the only China-based vaccine company that possesses all five proven human vaccine platform technologies worldwide, namely bacterial vaccine technologies, viral vaccine technologies, genetically engineered vaccine technologies, combination vaccine technologies and mRNA vaccine technologies. As of 16 September 2022, AIM Vaccine operates four individual licensed manufacturing facilities (Rong'an Bio, AIM Honesty, AIM Kanghuai and AIM Weixin), with a designed annual production capacity of 25.0 million doses, 45.0 million doses, 5.3 million doses and 16.0 million doses, respectively, or 91.3 million doses in aggregate. Each licensed manufacturing facility is responsible for producing one or more specific types of vaccines with different production processes and techniques. According to CIC, vaccine quality and safety attributes are highly dependent on the production processes and techniques, which take time to accumulate and are very hard to copy or switch. In addition, vaccine companies in China are generally prohibited from outsourcing manufacturing to CMOs. As a result, these four individual licensed manufacturing facilities create a highly competitive edge for the Group. By equipping AIM Vaccine with extensive hands-on experiences, process know-how and ready-for-use large-scale production capacity for multiple vaccine products, they enable AIM Vaccine to promptly respond to increasing commercial demand and shorten vaccine development cycle.

AIM Vaccine has established a comprehensive quality management from vaccine research, development and manufacturing, with high and consistent quality as the Group's top priority. All the Group's four licensed manufacturing facilities have maintained 100% pass rate in vaccine lot release quality audits by the National Institutes for Food and Drug Control ("NIFDC") under the Group's operation, higher than the industry average level, according to CIC. AIM Vaccine is the only human rabies vaccine manufacturer with 100% pass rate in lot release quality audits by NIFDC over the past five years, and the Group's 10ug HBsAg/0.5ml recombinant HBV vaccine (Hansenula Polymorpha) has maintained 100% pass rate in lot release quality audits for 15 years since commercial launch.

Extensive sales network and highly experienced and efficient commercialization team

The Group's sales and marketing function is centralized, and is specialized and market-oriented. AIM Vaccine's in-house sales and marketing team, consisting of over 100 members with an average of more than 10 years' experience in sales of pharmaceuticals or vaccines. AIM Vaccine's core commercial leadership team has an average of 12 years of experiences in vaccine commercialization in leading multinational pharmaceutical companies, and has excellent track records in marketing international blockbuster vaccines, including global first HPV, IPV and DTaP-IPV-Hib. AIM Vaccine consolidates and integrates quality resources at the Group level instead of dispersing into four operating subsidiaries, which enables AIM Vaccine to achieve a high cost-efficiency, especially in team building and management. Through the sales and marketing centralization, AIM Vaccine has built effective sales channels for and strong CDC recognition of the Group's products, enabling AIM Vaccine to cross-sell existing vaccine products and rapidly ramp up sales of vaccine products. As of 16 September 2022, AIM Vaccine sold vaccine products to all 31 provinces, direct-controlled municipalities and autonomous regions in the PRC, covering all provincial CDCs and over 2,000 county-level CDCs.

Visionary founder with strong support from experienced execution team and industry-leading scientists

AIM Vaccine's core management team comprises a group of seasoned vaccine industry professionals with a strong track record and proven execution capabilities. The industry experience, management expertise, professional knowledge and contributions of key members of the senior management are crucial to the Group's success. AIM Vaccine has leading scientists joining or collaborating with AIM Vaccine to support the Group's vaccine development and manufacturing. Within the group, AIM Vaccine has also established a Group-level vaccine expert panel. In addition, outside the group, AIM Vaccine has established a scientific advisory board that comprises prominent scientists in China's vaccine industry to offer advice and recommendations on the direction of the Group's R&D efforts. These scientists, in together, have and would continue to cultivate their scientific insights, deep industry knowledge and rich experience in the Group's vaccine development and production processes, and have helped to shape a dedicated, quality-forward and market-oriented culture in the Group.

Vaccines have been one of the most important innovations in the science of public health, China has increasing demand from all age groups for high-quality vaccines. Including the COVID-19 vaccine market, the overall PRC vaccine market is expected to increase from RMB303.6 billion in 2021 to RMB431.4 billion in 2030. Leveraging its strong R&D capabilities and mass-scale manufacturing capabilities, to capture opportunities arising from the massive and underserved vaccine market in the PRC, the Group plans to advance R&D of the Group's vaccine candidates and to continue to enrich the Group's vaccine pipeline, construct new production facilities to expand production capacity for new vaccine products, as well as further invest in sales and marketing. Looking forward, AIM Vaccine will continue to realize its mission to "develop and manufacture top quality vaccines to safeguard the health of the world" through a diversified product portfolio, and strive to become a leader in the global vaccine industry.

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

HKTDC launches GoGBA Day

HONG KONG, Sep 23, 2022 – (ACN Newswire) – The Hong Kong Trade Development Council (HKTDC) and the Guangdong-Hong Kong-Macao Greater Bay Area Development Office co-organised the inaugural GoGBA Day yesterday (22 September). This business support event aims to engage members of the international business community in Hong Kong that are currently underserved in terms of up-to-date business information on the Guangdong-Hong Kong-Macao Greater Bay Area (GBA). The physical part of the hybrid on-site/online event was held at the HKTDC SME Centre at the Hong Kong Convention and Exhibition Centre.


The GoGBA Day was launched yesterday (22 September) at the HKTDC SME Centre. The event began with welcome remarks from HKTDC Executive Director Margaret Fong (fourth from left, front row), followed by speeches delivered by honourable speakers.

GoGBA WeChat mini programme (QR Code)


The half-day event featured a series of seminars offering practical business tips and updates on the latest developments in the GBA to prepare international enterprises to "go GBA" via Hong Kong. The event received an overwhelming response with more than 160 participants attending the seminars at the venue while 260 participants joined the online webinar. At the same time, 65 business advisory sessions and one-on-one consultation meetings were arranged for 47 companies at the venue to facilitate business partnerships and opportunities.

The joint seminars welcomed officials from various authorities in the GBA, along with industry leaders and market experts from banking and other sectors, to share their insights and business know-how with international medium-sized enterprises and start-ups, helping them get equipped to set up business and succeed in the GBA via the Hong Kong platform. A wide range of topics was discussed, including the business landscape in the GBA and key incentives and subsidies for start-ups and businesses in the areas of tax, banking and investment.

Welcoming participants to the event, HKTDC Executive Director Margaret Fong said: "The GBA plan attracts attention not only because the GBA has China's highest GDP at US$1.96 trillion, but it offers basically everything a business needs to grow, from the international financial hub of Hong Kong and the world-class manufacturing centres across Guangdong, to the advanced innovation and tech clusters across the region – not to mention a huge market of 86 million people and a stepping stone to the vast Mainland China market."

Ms Fong continued: "We launched our GoGBA support programme last year to help businesses navigate the GBA through Hong Kong by offering information, advisory support and networking and marketing platforms. The GoGBA Day is a highlight of our programme, bringing together the Hong Kong family of organisations under one roof to introduce their GBA support programmes and services, enabling us to hold a GBA event specifically for the international business community for the first time. We hope to give them not only an overview of the latest GBA developments, but also offer practical information to help them make decisions and take action."

Officials explain GBA business landscape, supporting initiatives and keys to success

Tommy Yuen, Commissioner for the Development of the Guangdong-Hong Kong-Macao Greater Bay Area, said: "The GBA is more than a key national development strategy under China's reform and opening up. It is also marked a further step towards enriching One Country, Two Systems and promoting coordinated economic development that can turn the region into a world-class area for living, working and travelling. New measures are continually being implemented, including steps to encourage the development of private equity and venture capital funds in Qianhai and improving land boundary crossing facilities to enhance talent mobility between Hong Kong and GBA cities. In the coming decade, the GBA is set to become the world's most vibrant and rapidly growing economic region."

Jimmy Chiang, Associate Director-General of Investment Promotion (Business Development) of Invest Hong Kong, said: "President Xi Jinping has emphasised the importance of leveraging and strengthening Hong Kong's unique advantages as an international financial, shipping and trading centre, as well as its convenient links to international markets. The 14th Five-Year Plan also highlighted the country's support for Hong Kong in traditional industries as well as four emerging areas, including aviation, innovation and technology, intellectual property trading and international cultural exchange. These specific sectors will see more development opportunities in Hong Kong, and the GBA's growth will create many attractive opportunities for international companies."

Kenneth Wong, General Manager, MICE & Cruise, Europe, Hong Kong Tourism Board, said: "The Hong Kong Tourism Board has developed a tourism recovery framework to aid in the recovery, reopening and rebranding of Hong Kong's tourism industry. We devised a number of publicity and promotion campaigns to maintain Hong Kong's visibility during the pandemic and to facilitate tourism as well as MICE recovery. This includes bringing back large-scale international events and establishing a dedicated team to provide MICE organisers with one-stop support. Hong Kong can connect international visitors to the GBA's tremendous business opportunities, generate attendance for organisers, facilitate professional visits and excursions to other GBA cities."

Raymond Yip, Chief Liaison Officer of the Guangzhou Nansha Service Centre in Hong Kong, said: "The Central Government hopes that Nansha, with its strategic location at the heart of 10 GBA cities, will become a cooperation and collaboration hub for the GBA. Nansha has a broad and diverse industry base with advanced manufacturing, as well as a state-level science and technology forum. With no fewer than 20 policy measures for Hong Kong and Macao, including allowing people from Hong Kong, including foreigners, to pay Hong Kong taxes, Nansha is set to open up a larger hinterland for Hong Kong."

Witman Hung, Principal Liaison Officer for the Hong Kong, Shenzhen Qianhai Authority, said: "Qianhai has always been a pilot zone to help China open up and deepen its reforms. Promoting and facilitating collaboration between Hong Kong and Shenzhen is high on our priority list. For example, we have incubated 335 Hong Kong start-ups and assisted the city's professionals such as lawyers, engineers and architects in entering the mainland market. Recently, the Qianhai Authority and the Hong Kong government announced 18 new measures aimed at encouraging venture capital and private equity to enter China via Qianhai and Hong Kong. Hong Kong-based companies will be able to use Qianhai as a shopfront to provide professional services to the rest of the GBA and Mainland China."

Vivian Cheung, Executive Director, Airport Operations, Hong Kong International Airport, said: "We have been expanding the capacity and functionality of Hong Kong International Airport in preparation for the resumption of international travel and business. The SKYCITY development is at the heart of this, featuring a new 3.8 million sq ft complex, with recreational facilities and three new office towers. New hotels will also be built and we are revamping services to provide better travel and transit experiences for passengers. Furthermore, we are transforming AsiaWorld-Expo into a 20,000-seat arena, adding new passenger and cargo handling facilities and constructing new infrastructure to make it easier for Hong Kong to connect with the GBA."

Background to the Guangdong-Hong Kong-Macao Greater Bay Area

The Guangdong-Hong Kong-Macao Greater Bay Area (GBA) promotes Hong Kong's integration into Mainland China's national development by accelerating the socio-economic integration of Guangdong, Hong Kong and Macao. Hong Kong has been designated as an international financial, shipping, trade and aviation hub, a global offshore renminbi business hub and an international centre for asset management and risk management. As a value-added financial, trading, logistics and professional services centre, supporting technology and innovation, Hong Kong is also a centre for international legal and dispute resolution in Asia-Pacific.

HKTDC's array of services support enterprises entering the GBA

Over the years, the HKTDC has worked hard to facilitate cooperation between Guangdong and Hong Kong. To support companies in doing business in the GBA, the HKTDC shares useful official information on regulations, procedures and networks through its GoGBA website ( https://www.go-gba.com/en/ ) and WeChat mini-programme, the latter also offering tools such as public health updates, maps, transportation guides and a day counter for individual income tax purposes. As of mid-September 2022, more than 506,700 views of the HKTDC's GoGBA digital platforms had been recorded.

On the ground, the HKTDC has established the HKTDC GBA Service Centre in Shenzhen to provide local and international enterprises from Hong Kong with consultation services, industry-related updates and business matching. The Service Centre has so far organised more than 70 activities, with about 3,000 Hong Kong enterprises using its services. Working together with mainland partners, the HKTDC has also set up GoGBA Business Support Centres in Qianhai (Shenzhen), Nansha (Guangzhou), Hengqin (Zhuhai), Dongguan and Zhongshan, with Foshan being added later this year, to provide Hong Kong enterprises with policy and market consultation services.

In addition, the HKTDC's Transformation Sandbox (T-box) programme will extend its services from Hong Kong to Shenzhen and other cities in the GBA. Together with its Digital Academy and E-Tailing Academy, the HKTDC will provide advisory workshops related to e-commerce and digital business as well as marketing solutions and other digital platforms.

The GBA presents enormous opportunities for businesses from Hong Kong and around the world and the HKTDC will continue to devote efforts to support local and international enterprises in the city, helping them seize business opportunities in the GBA and other mainland markets through its network of 13 offices in the mainland. It also plans to organise the Hong Kong-Guangdong Co-operation Week this year, including the annual SmartHK and Chic HK flagship events in Shenzhen and Guangzhou, along with a series of roadshows related to financial management, legal services, infrastructure development and real estate, as well as participating in key trade fairs in the mainland.

GoGBA WeChat mini programme (QR Code)

HKTDC SME Centre
Tel: +852 1830 668
Fax: +852 3693 4938
E-mail: smecentre@hktdc.org
Address: Ground Level, Hong Kong Convention and Exhibition Centre, 1 Expo Drive, Wan Chai, Hong Kong

HKTDC GBA Centre
Tel: 0755-82280112
Fax: 0755-82280114
E-mail: shenzhen.office@hktdc.org
Address: Unit 2405-06, Jindi Centre, Shennan Road 2007, Futian District, Shenzhen

GoGBA Day Website: https://go-gba.com/en/gogbaday.html
"Greater Bay Area, Great Future" promotional video (provided by the Guangdong-Hong Kong-Macao Greater Bay Area Development Office): https://www.bayarea.gov.hk/en/stories/videos.html
More about the Guangdong-Hong Kong-Macao Greater Bay Area https://hkmb.hktdc.com/en/guangdong-hongkong-macao-greater-bay-area
Photo download: https://bit.ly/3UyJSpU

About HKTDC

The Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on Twitter @hktdc and LinkedIn

Media enquiries
Please contact the HKTDC's Communications & Public Affairs Department:
Kate Chan, Tel: +852 2584 4239, Email: kate.hy.chan@hktdc.org


Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

‘Strive and Rise’: Deloitte Foundation Hong Kong uplifts youth for brighter futures

HONG KONG, Sep 23, 2022 – (ACN Newswire) – Deloitte Foundation Hong Kong has donated HKD1 million to support the Hong Kong SAR government's Strive and Rise Programme, launched timely to address intergenerational poverty by helping underprivileged children, particularly those living in subdivided accommodation, realize their potential.



In addition to a financial contribution, 50 professionals from Deloitte China will join the program as mentors to boost the confidence of target students, build their life skills, guide them to develop personal goals and explore different development possibilities. The firm will also organize a range of group activities that provide mentees with diversified learning and development opportunities, including firm visit, job-shadowing workshop, and experience sharing by Deloitte's senior management.

Deloitte China CEO Patrick Tsang says, "For Hong Kong to continue to thrive as a global city, now more than ever we need to build a caring, inclusive society, and enhance the upward mobility of our youths by fighting intergenerational poverty in our communities."

"We are committed to playing our part as a socially responsible member of society by contributing our resources, expertise, and network to nurture this next generation. It is a great honor to support such an important initiative, and we call on more companies to join us in this cause."

In line with the Chief Executive John Lee's policy vision to tackle intergenerational poverty and boost youth upward mobility, the year-long Strive and Rise Programme was launched this month to match the first cohort of 2,000 underprivileged junior secondary students with trained mentors from professional backgrounds. These professionals will help mentees set positive life goals and strive for upward mobility through a structured program that comprises training sessions, interactive discussions, eye-opening group visits, and network building events.

Deloitte China Southern Region Managing Partner and Deloitte Foundation Hong Kong Secretary-General Edward Au says, "Youth development is a strategic focus area under our WorldClass initiative to positively impact 15 million people in China by 2030. To realize this ambitious vision, we've been working closely with the Hong Kong community to roll out multiple programs that support our youth in education, skills, and opportunities."

Since 2009, Deloitte's "Pass The Torch" student mentorship program has provided over 300 underprivileged secondary students with mentoring opportunities, helping them build confidence, broaden their worldview and future possibilities. In addition, the firm has collaborated with a youth association to organize "Career Dimensions" workshops since 2019, helping more than 1,900 secondary students identify their education and career aspirations, and develop future proof skills.

"The Strive and Rise Programme aligns with our promise to make an impact that matters by helping young people unleash their full potential. We are proud to support this meaningful initiative, as part of our HKD1 billion investment to further the development of our Hong Kong practice under our INspire HK strategy. As a purpose-led and responsible organization, we will strive to inspire Hong Kong's next generation with compassion, respect, and positivity to guide them toward a brighter future," Au adds.

Details of the program can be found here. https://www.striveandrise.gov.hk/en/programme-overview/

About Deloitte China

Deloitte China provides integrated professional services, with our long-term commitment to be a leading contributor to China's reform, opening-up and economic development. We are a globally connected and deeply locally-rooted firm, owned by its partners in China. With over 20,000 professionals across 30 Chinese cities, we provide our clients with a one-stop shop offering world-leading audit & assurance, consulting, financial advisory, risk advisory, business advisory and tax services.

We serve with integrity, uphold quality and strive to innovate. With our professional excellence, insight across industries, and intelligent technology solutions, we help clients and partners from many sectors seize opportunities, tackle challenges and attain world-class, high-quality development goals.

The Deloitte brand originated in 1845, and its name in Chinese denotes integrity, diligence and excellence. Deloitte's professional network of member firms now spans more than 150 countries and territories. Through our mission to make an impact that matters, we help reinforce public trust in capital markets, enable clients to transform and thrive, and lead the way toward a stronger economy, a more equitable society and a sustainable world.

About Deloitte

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited ("DTTL"), its global network of member firms, and their related entities (collectively, the "Deloitte organization"). DTTL (also referred to as "Deloitte Global") and each of its member firms and related entities are legally separate and independent entities, which cannot obligate or bind each other in respect of third parties. DTTL and each DTTL member firm and related entity is liable only for its own acts and omissions, and not those of each other. DTTL does not provide services to clients.

Deloitte Asia Pacific Limited is a company limited by guarantee and a member firm of DTTL. Members of Deloitte Asia Pacific Limited and their related entities, each of which are separate and independent legal entities, provide services from more than 100 cities across the region.

Please see www.deloitte.com/about to learn more.

Disclaimer

This communication contains general information only, and none of Deloitte Touche Tohmatsu Limited ("DTTL"), its global network of member firms or their related entities (collectively, the "Deloitte organization") is, by means of this communication, rendering professional advice or services. Before making any decision or taking any action that may affect your finances or your business, you should consult a qualified professional adviser.

No representations, warranties or undertakings (express or implied) are given as to the accuracy or completeness of the information in this communication, and none of DTTL, its member firms, related entities, employees or agents shall be liable or responsible for any loss or damage whatsoever arising directly or indirectly in connection with any person relying on this communication. DTTL and each of its member firms, and their related entities, are legally separate and independent entities.

Contact: Ashley Leung
Tel: +852 2109 5261
Email: asleung@deloitte.com.hk

Contact: Lyanna Chan
Tel: +852 2238 7111
Email: lyachan@deloitte.com.hk

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Mediwelcome Announced 2022 Interim Results

HONG KONG, Sep 23, 2022 – (ACN Newswire) – A China's leading provider of digital medical service solutions – Mediwelcome Healthcare Management & Technology Inc. ("Mediwelcome" or the "Company", and together with its subsidiaries, the "Group") (Stock Code: 2159), announced the unaudited consolidated interim results for the six months ended 30 June 2022 (the "Reporting Period" or the "First half of 2022").



In the first half of 2022, Mediwelcome has narrowed in revenue and other aspects to varying degrees due to the continuous lockdown in many provinces in response to the severe pandemic in the PRC. In the first half of 2022, Mediwelcome's revenue decreased by approximately 49.2% to approximately RMB172.5 million YoY. Gross profit was approximately RMB17.3 million. During the Reporting Period, the Group's primarily generated revenue from medical conference services, marketing strategy and consulting services, and patient education and screening services, etc.

Continuously expanding the medical digital marketing solutions and online healthcare platforms, and striving for digital upgrading

Although the economic environment is facing great challenges under the epidemic situation, Mediwelcome always insists on continuously expanding and consolidating its integrated healthcare marketing solutions and made a concerted effort to develop its online healthcare platforms and fully implemented digital upgrade for the businesses. During the Reporting Period, medical conference services was the main revenue stream and recorded revenue of approximately RMB111.3 million, accounting for 64.5% of the total revenue. To strengthen the Group's conference management capabilities, Mediwelcome has launched the Conference+ App for medical NGOs and pharmaceutical companies to submit onsite conference requests and monitor conference implementation. In terms of marketing strategy and consulting services, through this service, the Group assisted pharmaceutical companies in formulating and implementing effective business strategies in enhancing their brands and product awareness among physicians. During the Reporting Period, marketing strategy and consulting services recorded revenue of approximately RMB41.3 million, accounting for 23.9% of the total revenue. Patient education and screening services and CRO services recorded revenue of approximately RMB14.3 million and RMB3.7million, accounting for 8.3% and 2.1% of the total revenue, respectively.

As of June 2022, the Group has developed and iterated multiple medical digital marketing platforms and products to provide customers with customised medical digital marketing solutions, including the Giraffe Smart Medical Platform, Digital Patient Management Platform, E Conference, Giraffe Live, Deer Class, E Creation, E Insight and other products. As at 30 June 2022, the digital platforms have enrolled 384,965 registered doctor users, held 46,518 online education sessions with doctors and 25,687 online education sessions for patients, livestreamed 4,855 times, with 6,319 videos available and viewed by 1,086,328 visitors.

Meanwhile, Mediwelcome has sustained its effort to develop and expand its online healthcare platforms to cater for the increasing needs of various stakeholders in the medical field, including hospitals, doctors as well as pharmaceutical and medical equipment companies. The Group's online healthcare platform, on top of providing doctors and patients with consistent and quality online medical service solutions, has also actively developed products and services of digital management for patients with chronic illnesses in the out-of-hospital context. As at 30 June 2022, the number of its registered doctor and patient users has reached 45,244 and 200,545, representing an increase of 69.9% and 321.2% YoY, respectively. In addition, due to the increase in the number of active patient users purchasing prescribed medicine through the Group's internet hospital platform, revenue from internet hospital services increased by approximately 5.6% to approximately RMB1.9 YoY.

Continuously upgrading the digital marketing business, seizing the growth opportunities to create greater value

Looking forward, Mediwelcome will continue to enhance the scale of digital marketing business, and utilize its internal and external strengths and resources and focus more on customer development for digital marketing in the healthcare market. At the same time, the Group will sustain its effort to build a digital platform with precise access targeting doctors and patients, providing customers with integrated digital and intelligent marketing solutions using a digital integrated marketing system synergised by both offline and online channels, so as to create a closed loop for the whole process of digital operation. The Group will continue to upgrade its online healthcare platform and explore the application of AI technology to build a closed-loop business model from inside to outside hospitals. In addition, Mediwelcome will also leverage the favorable health policy environment and its own resources to maintain revenue growth of its professional medicine and marketing services in the traditional cardiovascular and cerebrovascular discipline, with a focus on expanding its business in the fields of oncology and chronic renal diseases to increase the coverage of customers from domestic enterprises.

The Group will continue to maintain its business scale in the traditional dominant therapeutic fields, and actively drive innovation in order to seize the opportunities arising from the rapid growth in demand for medical digital marketing and online healthcare for its steady development. While actively generating profits under its efficient operation, the Group persistently expands and develops its business model and scale to create greater value for more customers, doctors and patients.

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Malaysian Genomics Grows Presence in Thailand

PETALING JAYA, Malaysia, Sep 23, 2022 – (ACN Newswire) – Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce today a series of collaborations to grow its customer base in Thailand as well as exploring opportunities for research and development (R&D) of new products and services.


Ms. Songsuda Panich, Founder of Marine Group; Encik Sasha Nordin, Chief Executive Officer of Malaysian Genomics; Mr. Choy Hong Yang, Director of Salus Holdings [L-R]

Chief Executive Officer of Malaysian Genomics, Encik Sasha Nordin


The Group signed a supply and collaboration agreement with Acquest Healthcare Stem Cell Research and Development Co. Ltd. to produce CAR T-cells for supply to Acquest's customers. Acquest is a well-established provider of various cell therapies to hospitals, specialist doctors, and patients in Thailand. It operates a state-of-the-art clinical laboratory and also the largest privately-owned specialty human cell culturing facility in the country.

The Group also signed a supply and collaboration agreement with Salus Holdings Co. Ltd. ("Salus") to supply biopharmaceutical and genomics products and services to Salus' customers. Salus is a specialist in wellness and health screening using science and technology for early disease detection and managing programmes for lifestyle intervention based in Bangkok, Thailand.

Finally, the Group signed a Letter of Intent with Marine Group Co. Ltd. and Salus on collaborative research in the use of genetic screening tests and formulated cosmetic products containing certain cell therapy ingredients on the regeneration of skin and hair of patients. Marine Group is an aesthetic and wellness specialist with a network of over 42 centres under the brands Slim Up(TM), Skin Doctors(TM), and Biocell(TM).

The signing ceremony was attended by His Excellency Dato' Jojie Samuel, Ambassador of Malaysia to Thailand and Encik Mohamed Hafiz Md Shariff, Trade Commissioner of MATRADE Bangkok.

Chief Executive Officer of Malaysian Genomics, Encik Sasha Nordin, said, "We are looking forward to a fruitful relationship with our Thai partners, Salus and Acquest. These collaborations are part of our strategy of growing our customer base and increasing our presence overseas through working with business partners who have an established presence in their respective market segments."

Dr. Roland Neff, CEO of Acquest, said, "This collaboration is the first step as both parties explore the possibilities of conducting joint R&D that can result in new products and services that can be commercialised. We have a state-of-the-art clinical laboratory in Bangkok and also the largest privately-owned specialty human cell culturing facility in the country."

Mr. Choy Hong Yang, Director of Salus, said, "At Salus, we use science and technology to provide services on disease detection, prevention and life-span improvement. This collaboration with Malaysian Genomics will enable us to leverage on their genetics knowledge and expertise to offer more products and services while the strategic cooperation is in keeping with our core value of joint innovation to offer new technologies to our customers."

Ms. Songsuda Panich, Founder of Marine Group, said, "Skin Doctor, Slim Up and BioCell centres are always striving to provide the latest in skin and aesthetic science and technology for our customers. We look forward to collaborating with Malaysian Genomics and with Salus Healthcare on research and development involving cell regeneration products."

Malaysian Genomics Resource Centre Berhad: 0155 [BURSA: MGRC] [RIC: MGRC:KL] [BBG: MGRC:MK], http://www.mgrc.com.my/

Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com

World Cyber Security Summit in Jordan brought together global cyber security experts to tackle the battle against cyber threats

Jordan, Sept 22, 2022 – (ACN Newswire) – On 15 – 16 August 2022, an in-person event featuring a richness of debates about future technology and cyber security was held in Jordan. The event’s organiser, Trescon and its Strategic Partner JOCSA (Jordan Cyber Security Association) hosted more than 500 C-level attendees, including key stakeholders in the cyber security ecosystem, such as government officials, top experts in the field, solution providers, startups, media, among others.

A picture of the panel discussion from the World Cyber Security Summit – Jordan that was streamed live on August 15-16, 2022

Leading players in Cyber security space like Green Circle, Agualetica, BeeezCrowd, Alpha Hub, Mandiant, CloudSEK, ManageEngine, and Wizard Cyber gathered at the event to examine the prospects for Cyber Security in Jordan.

The event featured a ground-breaking alliance between specialists like:

  • Scott E. Augenbaum – Retired FBI Supervisory Special Agent; Author; Cybercrime Prevention Trainer, Scott Augenbaum LLC
  • Glen Thomas – Partner – Head of Technology and Cyber Consulting, Grant Thornton, United Arab Emirates
  • Dr. Haidar Fraihat – Cluster Leader – Statistics, Information Society, and Technology, United Nations Economic and Social Commission for Western Asia (ESCWA), Lebanon
  • Jacob Mathew – Head of Information Technology, Government of Abu Dhabi Entity, United Arab Emirates
  • Nicole Lau – Sales Director, Verimatrix, Oslo, Norway
  • Ricoh Danielson – CEO, 1st Responder, an Incident Response Firm, United States
  • Eng. Abdullah Faisal Biary – CISO, United Cooperative Assurance, Saudi Arabia
  • Taha Hussain – Information Security Specialist, Dubai Electricity & Water Authority – DEWA, United Arab Emirates
  • Dr. Hossam Elshenraki – Associate Professor, Dubai Police HQ, United Arab Emirates
  • Eng. Mona Alshehri – Risk and Compliance Analyst, Saudi Air Navigation Services, Saudi Arabia
  • Dr Ahmed Abd El Hady Mohamed – Director of Quality in General Administration for Quality and Environmental Affairs, Holding Company for Water and Waste Water (HCWW), Egypt
  • H.E. Belal Hafnawi – Commissioner – Board Member,Telecommunications Regulatory Commission (TRC-Jordan), Jordan
  • Nada Khater – Head of Digital Transformation Policies and Strategies, Ministry of Digital Economy & Entrepreneurship, Jordan
  • Eng. Lama Arabiat – Head of AI, Ministry of Digital Economy and Entrepreneurship, Jordan
  • Dr. Ashraf Ahmad – Dean – Princess Sumaya University for Technology (PSUT), Open Source Intelligence in Arabic Challenges and Solutions, Jordan & many more elite speakers to name a few.

The show kicked off with an opening keynote by Nidal Al-Bitar, CEO, Information and Communications Technology Association of Jordan (Intaj), where he shared his insights on the topic ‘Employment in the Cyber Security’ by quoting, “As companies mature on their digital transformation journeys, cybersecurity remains the biggest concern: 69 per cent of US executives believe cyber security is the biggest AI-related risk.”

Abdulrahman Al-Nimari, VP, Cyber Security from Saudi Arabia spoke at length on ‘Zero Trusting Your Enterprise. He was quoted saying, “You believe that if this gadget is making a call to an external network, it is making a positive call because we believe in that device. However, the call is essentially a command-and-control request to the internet to obtain the ransomware’s symmetric key. Therefore, by authorising that outbound connection, you are personally enabling the attack.”

While speaking about ‘Building a Resilient Cybersecurity Organization’, George Eapen, Group CIO, Petrofac mentioned that, “For the right security outcome, CISO must build an ecosystem consisting of complementary solutions/partners/team.”

The event also witnessed a panel discussion on the topic ‘Leveraging AI in Threat Intelligence to Enable Protection from Advanced Threats’ that was moderated by Dr. Hossam Elshenraki

“It comes down to the fact that cybersecurity is a shared duty and that the more systems we secure, the safer we are all. We’re happy to have hosted World Cyber Security Summit in Jordan, and loved the support we received from the tech fraternity in Jordan with the help of international delegates, sponsors, thought leaders, and media among others,“ says Mohammed Saleem, Founding Chairman, Trescon.

The 17th global edition of World Cyber Security Summit – Jordan is supported by Hashemite Kingdom of Jordan and the Ministry of Digital Economy and Entrepreneurship, Jordan and officially sponsored by:

World Cyber Security Summit – Jordan was Officially Supported by the following Media Partners:

Official Media Partner:

· Almamlaka tv

Official Newspaper Partner:

The Jordan Times

Media Partners:

About World Cyber Security Summit

World Cyber Security Summit is a thought-leadership-driven, business-focused initiative that provides a platform for CISOs who are looking to explore new-age threats and the technologies/strategies to mitigate them.

The Summit fuses CISOs across industry sectors from Jordan who meet, network, learn and engage with some of the world’s renowned technology thought-leaders, subject matter experts, and technology innovators in a constructive, open-dialogue environment to find solutions for issues hindering their information/cyber security.

About Trescon

Trescon is a global business events and consulting firm that provide a wide range of business services to a diversified client base that includes corporations, governments, and individuals. Trescon is specialized in producing highly focused B2B events that connect businesses with opportunities through conferences, roadshows, expos, demand generation, investor connect, and consulting services.

For further details, please contact:
Nupur Aswani
Head – PR, Media & Corporate Communications, Trescon
+919555915156 | media@tresconglobal.com



Copyright 2022 ACN Newswire. All rights reserved. http://www.acnnewswire.com